partnership

An open book with pages turning on a wooden table set

Erasca looks to partner off late-stage melanoma asset

The asset, which Erasca picked up from Novartis for $20 million, would be the first targeted therapy in NRASm melanoma if it were to make it to market.

Gabrielle Masson May 13, 2025 10:38am

BioAge secures Novartis deal worth up to $550M biobucks

Dec 18, 2024 10:44am

Two businessmen pushing giant puzzle pieces together as the sun sets behind them

Acepodia, Pfizer click together for chemistry-based cell therapy

Sep 3, 2024 5:00pm

JPM24: Flagship unveils life sci tech-focused initiative

Jan 9, 2024 12:58pm

deal handshake business cooperation partnerships

WuXi CRDMO spinoff WuXi XDC partners with IntoCell

Jan 3, 2024 11:05am

48% of biotechs relying on Big Pharma for funding: ICON survey

Dec 18, 2023 9:00am